Sign in to view content

Higher Order OCT Feature Assessment of the Impact of Fluid Dynamics on Visual Acuity in Neovascular AMD in a Phase III Clinical Trial: The Importance of Outer Retinal Integrity

Justis P. Ehlers, MD, FASRS

Video
Published 2022

Related

ENVISION Trial 24-Week Data: Phase 2 Study of UBX1325, a New Senolytic Agent for Patients With Wet AMD
Raj K. Maturi, MD
Annual Meeting Talks
2023
Suprachoroidal Delivery of RGX-314 for Neovascular AMD: Initial Results From the Phase II AAVIATE Study
Mark R. Barakat, MD
Annual Meeting Talks
2021
Episode 131: Journal Club on Follow-up for AMD and PDR Patients, Phase II and III Clinical Trials, Ophthalmology Chairs in the U.S. with Dr. M. Ali Khan
Jayanth Sridhar, MD
Member Podcasts
2018

Category: AMD-Neovascular

See more